MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to describe activity and toxicity of single-agent
gemcitabine given as prolonged infusion, and of two 2-drug combinations containing cisplatin
(cisplatin + vinorelbine, and cisplatin + gemcitabine) in the treatment of elderly patients
with advanced non small cell lung cancer